Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

An FDA Age-Based Predicate Policy Would Be Arbitrary, Reg Experts Complain

Dec 12 2018

• By Elizabeth Orr and David Filmore

Business development idea and developing industry success through creative invention as a light bulb evolving to a gear shape as a 3D illustration.

Related Content

CDRH Drops Seven Divisive 510(k) Proposals; Congress Picks Some Up

Feb 27 2012

FDA's Alternative 510(k) Proposal Falls Flat With Industry

Jul 20 2018

Nudging Firms To Ditch Older Predicates: A Step In US FDA's Planned 510(k) Reforms

Nov 27 2018

'Quik' Review Program Builds On US FDA eSubmission Efforts

Sep 05 2018

Appeals Court Checks FDA On Its 510(k) Rescission Authority

Sep 29 2014

Additional Topics

United States FDA Regulation Policy Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window